Level Bio AB (publ) (NGM:LEVBIO)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.1910
-0.0390 (-16.96%)
At close: Oct 14, 2026

Level Bio AB Revenue

Level Bio AB had revenue of 9.20M SEK in the quarter ending June 30, 2026, with 9.80% growth. This brings the company's revenue in the last twelve months to 34.37M, up 14.34% year-over-year. In the year 2025, Level Bio AB had annual revenue of 32.36M with 28.95% growth. That makes Level Bio AB the 41,061st largest company in the world by revenue and 593rd in Sweden.

Revenue (ttm)
34.37M
Revenue Growth
+14.34%
P/S Ratio
0.46
Revenue / Employee
3.44M
Employees
10
Market Cap
13.06M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202532.36M7.26M28.95%
Dec 31, 202425.10M-999.39K-3.83%
Dec 31, 202326.10M-8.24M-23.99%
Dec 31, 202234.33M-9.63M-21.90%
Dec 31, 202143.96M20.43M86.86%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Valuno Group AB666.58M
Vaxxa AB92.78M
Transiro Holding AB26.57M
Qbrick AB24.28M
Hybricon AB16.98M
edyoutec AB4.87M
PolarCool AB2.82M
Odinwell AB160.28K
Revenue Rankings

Level Bio AB News

More News